CDC advisory committee unanimously recommends Pfizer’s pediatric COVID-19 vaccine
![cdc-update](/sites/default/files/styles/900x400/public/2018-07/cdc-update.jpg?itok=0cRUeHuZ)
The Centers for Disease Control and Prevention’s independent Advisory Committee on Immunization Practices today recommended Pfizer’s COVID-19 vaccine be administered for children ages five through 11. The 14-0 vote paves the way for the first doses to be administered to that age group, pending approval by CDC Director Rochelle Walensky, M.D. Across its deliberations, the committee urged thorough, clear communications with families of potential-but-rare side effects, including myocarditis, with information on symptoms and where to seek medical care.
Related News Articles
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…